(a)
CRR3
they are used for the purpose of mitigating CVA risk and are managed as such;
← (b) · All articles · (b) →
Source: EUR-Lex CELLAR · retrieved 2026-09-04 · Text as adopted (Official Journal); later amendments are not incorporated in this text.